INTRODUCTION
============

Actin was first reported to be in the nucleus \>40 yr ago ([@B33]). Initially, this finding was not widely accepted, as the level of actin in the nucleus was very low compared with that in the cytoplasm, there were concerns about the purity of isolated nuclei, nuclear filamentous actin (F-actin) could not be visualized, and functions for nuclear actin were unknown (for reviews, see [@B67]; [@B70]). These concerns have been addressed by recent studies, which have firmly established that actin is inside the nucleus. Such studies have identified antibodies that recognize nuclear actin ([@B20]; [@B58]) and elucidated the mechanisms regulating the nuclear localization of actin ([@B72]; [@B63]; [@B45]). Furthermore, functional studies have implicated actin in regulating transcription, chromatin remodeling, nuclear organization/structure, and DNA damage repair ([@B67]; [@B71]; [@B23]; [@B50]; [@B5]; [@B70]).

Recent studies have provided insight into the structure of nuclear actin. Fluorescence recovery after photobleaching (FRAP) and fluorescence correlation spectroscopy studies of green fluorescent protein (GFP)--tagged Actin indicate there are two pools of nuclear actin ([@B42]). One pool has a slower turnover rate and is believed to be polymeric actin. The other pool of actin turns over faster and could be monomeric or polymeric actin that is rapidly associating and dissociating with protein complexes in the nucleus. [@B4]) generated nuclear actin probes to label both monomeric and polymeric actin. They found that monomeric nuclear actin is punctate and localizes to nuclear speckles and sites of RNA processing. Submicrometer-length polymeric actin does not localize to chromatin and likely generates a viscoelastic structure within the nucleus ([@B4]). Recent studies from the same group implicate submicrometer actin filaments in DNA damage repair and nuclear oxidation ([@B5]). Although these studies have significantly advanced our understanding of nuclear actin, much remains to be learned about its structure, including what factors, such as actin binding proteins, regulate its architecture.

Certain circumstances can result in nuclear actin filament formation (for reviews, see [@B23]; [@B25]). Stressors, including heat shock, treatment with dimethyl sulfoxide, and ATP depletion, can induce intranuclear actin filaments termed actin rods ([@B17]; [@B47]; [@B28]; [@B46]; [@B68]; [@B45]). Although nuclear actin rods have primarily been studied in cultured cell systems, they have also been observed in vivo. Nuclear actin rods are observed in *Dictyostelium* spores and disappear as germination occurs ([@B57]). Similar rods are seen in patients with actin myopathies ([@B19]; [@B13], [@B14]). Expression of Lamin mutants in *Drosophila* larval muscles also results in nuclear actin rods ([@B11]). In addition, actin rod formation is linked to neurodegenerative diseases, including Alzheimer's, Huntington's, and Parkinson's diseases ([@B43]; [@B40]; [@B38]; [@B44]). These and other studies have led to the idea that actin rods form under conditions of cellular stress and function as a prosurvival mechanism. However, failure to remove the rods is toxic to cells ([@B39]). Alterations in the actin cytoskeleton or the nuclear import/export of actin also result in nuclear actin rods ([@B49]; [@B63]; [@B6]; [@B16]; [@B45]; [@B59]). In addition, nuclear actin rods are observed in cultured cells in response to extracellular signaling induced by cell spreading ([@B52]). As discussed earlier, DNA damage induces submicrometer nuclear actin filament formation, and these filaments play a critical role in repair ([@B5]). Together these findings suggest that nuclear actin filaments and rods have physiological functions and may occur in other in vivo contexts.

The structure and composition of nuclear actin rods remain unclear. Initially, nuclear actin rods were not believed to label with phalloidin. Such findings resulted in the idea that these rods are structurally distinct from cytoplasmic F-actin. Indeed, some nuclear actin rods have been shown to be composed of actin that is fully bound along its length by Cofilin ([@B46]; [@B45]); such Cofilin binding precludes phalloidin staining. Recent studies indicate that some nuclear actin rods are phalloidin positive ([@B54]; [@B5]; [@B15]; [@B52]; [@B59]). It is important to note that imaging conditions necessary to visualize the phalloidin-stained nuclear actin rods require that the cytoplasmic phalloidin signal be significantly overexposed. Thus it is unclear whether there are different types of nuclear actin rods---those that are phalloidin versus Cofilin positive---or the differential staining of the structures simply reflects nuclear actin rod dynamics.

Here we present our novel finding that *Drosophila* oogenesis, or follicle development, is a model for studying the structure and regulation of nuclear actin. The *Drosophila* ovary is composed of ∼15 ovarioles---chains of sequentially maturing egg chambers or follicles. Each follicle consists of ∼1000 somatic cells termed follicle cells and 16 germline cells, including 15 nurse or support cells and one oocyte. Oogenesis is divided into 14 morphological stages, from the germarium to Stage 14 (S14). Here we primarily focus on S5--9 of development. During these stages, the follicle cells transition from being mitotic (S1--6) to endocycling (S7--9), the nurse cells transition from polytene (S1--5) to polyploid (S6 and after) and are endocycling, the follicle is growing rapidly in size, and oocyte polarity is established (reviewed in [@B65]; [@B62]; [@B12]; [@B9]). We find by both subcellular fractionation and immunofluorescence studies that actin is in the nucleus during *Drosophila* follicle development. Specifically, during S5--9, varying levels of nuclear actin are observed in the nurse cell nuclei, and high levels are seen within the germinal vesicle (oocyte nucleus). Germline expression of GFP-tagged Actin results in nuclear actin rod formation in a percentage of the nurse cells and the germinal vesicle during these same stages. These rods are both Cofilin and phalloidin positive. We also find that manipulation of the actin binding protein Fascin, which we recently found localizes to the nucleus and nuclear periphery in addition to the cytoplasm ([@B21]; [@B74]), alters both endogenous nuclear actin and nuclear GFP-Actin rod formation. Our data suggest that Fascin modulates nuclear actin by regulating Cofilin. Thus *Drosophila* oogenesis provides an in vivo, multicellular system with which to uncover new means of regulating nuclear actin.

RESULTS
=======

Developmental regulation of nuclear actin
-----------------------------------------

Previously we found that germline expression of the actin-labeling reagents GFP-Utrophin and Lifeact-GFP resulted in nuclear actin rods in the nurse cells and/or germinal vesicles during S5--9 of *Drosophila* oogenesis ([@B61]). Because these reagents can stabilize endogenous actin structures, the stage-specific formation of nuclear actin rods suggests that nuclear actin might normally play an important role during this period of follicle development.

To address this possibility, we used a broad-specificity actin antibody that has been used to examine nuclear actin---anti--actin C4. This actin antibody recognizes a highly evolutionarily conserved region in actin and labels all types of vertebrate actin and actin in lower eukaryotes, including *Dictyostelium* and slime mold ([@B36]). The actin C4 antibody has been widely used to examine nuclear actin, including during oocyte development ([@B48]), in Cajal bodies in multiple cell types ([@B18]; [@B35]; [@B41]), in association with RNA Pol II ([@B27]), and during cellular senescence ([@B60]). Immunofluorescence images reveal that actin is indeed found in nuclei during early oogenesis (Supplemental Movie S1). Nurse cells during S5--9 exhibit varying levels of nuclear actin ([Figure 1, A--B′](#F1){ref-type="fig"}). Some nurse cells within a follicle have nuclear actin that exhibits a structured or blobby appearance, and other nurse cells within the same follicle exhibit a nuclear actin haze ([Figure 1, A--B′](#F1){ref-type="fig"}; orange arrows indicate structured nuclear actin; see quantification in [Figure 8E](#F8){ref-type="fig"} later in this article and Supplemental Table 1B). As follicle development proceeds (S10 and later), only unstructured or hazy nuclear actin is observed in the nurse cells ([Figure 1, C--D′](#F1){ref-type="fig"}). Nuclear actin is also observed in a subset of the follicle cells during early oogenesis (germarium-S7), with more follicle cells being labeled in the germarium-S5 and decreasing to only a few cells during S7 ([Figure 1, B and B′](#F1){ref-type="fig"}, blue arrows, and unpublished data). In addition, throughout oogenesis, the germinal vesicle exhibits a very high level of nuclear actin ([Figure 1, A--C′](#F1){ref-type="fig"}, yellow arrowheads, and unpublished data). The actin C4 antibody also labels some F-actin structures, including the muscle sheath (blue asterisk in [Figure 1, A--B′](#F1){ref-type="fig"}), follicle cell basal cortical actin and oocyte cortical actin (white arrows in Figure 1, B and B′), the ring canals connecting the nurse cells (white asterisk in [Figure 1, B and B′](#F1){ref-type="fig"}), and in S10A and later stages, the nurse cell cortical actin ([Figure 1, C--D′](#F1){ref-type="fig"}, and unpublished data). Supporting our immunofluorescence studies, subcellular fractionation analysis of whole ovaries indicates that a low level of actin is found in the nuclear fraction using both the actin C4 antibody and another actin antibody ([Figure 1E](#F1){ref-type="fig"}).

![Nuclear accumulation of actin is developmentally regulated. (A--D′) Maximum projections of two to four confocal slices of *wild-type* follicles. (A--D) Merged images of nuclear envelope (wheat germ agglutinin, WGA) in magenta and anti--actin C4 staining in green. (A′--D′) Anti--actin C4, white. Scale bars, 50 μm. The nurse cells during S5--9 exhibit varying levels of nuclear actin (A--B′), with some exhibiting structured actin (orange arrows) and others exhibiting a low haze of nuclear actin (unmarked). The germinal vesicles have very high levels of nuclear actin (A--C′, yellow arrowheads). In addition, actin is observed in the nuclei of a subset of the follicle cells during early oogenesis (B and B′, blue arrows). The actin C4 antibody also labels some F-actin structures, including the basal cortical actin of the follicle cells and the oocyte cortical actin during early oogenesis (B and B′, white arrows), the nurse cell cortical actin later in follicle development (\>S10A; C--D′), ring canals (B and B′, white asterisks), and the muscle sheath (A--B′, blue asterisk). (E) Representative Western blots of subcellular fractionation with four independent samples, labeled 1--4, of whole ovary lysates from *wild-type* flies (total lysate, cytoplasmic fraction, nuclear fraction) blotted for actin (actin C4 and JLA20), Fascin (two exposures), Lamin Dm0 (nuclear marker), and α-Tubulin (cytoplasmic marker). bl, blank lane; Lad, ladder with molecular weight markers labeled. Actin and Fascin are found in the nuclear fraction of *wild-type* ovary lysates.](2965fig1){#F1}

Given that the anti--actin C4 nuclear labeling pattern is unique, we wanted to verify the specificity of the antibody. By immunoblotting, the actin C4 antibody recognizes a single band the size of actin, just like another actin antibody (JLA20; Supplemental Figure S1A). Although this finding indicates that the antibody recognizes *Drosophila* actin, it is possible that the antibody also recognizes something nonspecifically by immunofluorescence. To address this possibility, we used a number of approaches. First, we attempted to use other actin antibodies---2G2 ([@B20]) and 1C7 ([@B58])---that have been used to examine nuclear actin in other systems. In our hands, neither of these antibodies, using multiple fixation conditions, labels nuclear structures within *Drosophila* follicles or recognizes *Drosophila* actin by immunoblot (Supplemental Figure S1, B--D, and unpublished data). This lack of labeling is not unexpected, as the antigen for 2G2 is a nonsequential region of actin found in the profilin--actin complex from rabbit skeletal muscle ([@B20]), whereas the antigen for 1C7 is a chemically cross-linked actin dimer, also from rabbit skeletal muscle, that is structurally similar to lower-dimer actin ([@B58]). Thus the conformation of *Drosophila* nuclear actin is likely sufficiently divergent to prevent labeling with these antibodies. Furthermore, these two nuclear actin antibodies label different nuclear actin structures within the same vertebrate cells ([@B58]; [@B3]). These findings suggest that nuclear actin likely exists in numerous conformations or structures that are only labeled by specific reagents ([@B32]).

In addition to these antibodies, we used DNase I, which labels monomeric or G-actin ([@B26]), to examine nuclear actin. We found that DNase I uniformly labels a blobby structure within the nurse cell nuclei that strikingly resembles the structure labeled by the actin C4 antibody ([Figure 2, A′′ and B′](#F2){ref-type="fig"}′, and unpublished data). Indeed, costaining showed that DNase I and actin C4 colocalize ([Figure 2, A--B′](#F2){ref-type="fig"}′, and Supplemental Movie S2). Of note, DNase I did not label the actin within the germinal vesicles ([Figure 2, A--B′](#F2){ref-type="fig"}′). Because the actin C4 antibody can label both monomeric and F-actin ([@B36]) whereas DNase I labels only monomeric actin, the actin C4 labeling within the nurse cell nuclei and the germinal vesicles may reflect the polymerization state of nuclear actin.

![The actin C4 antibody recognizes *Drosophila* actin. (A--E′′) Maximum projections of two to four confocal slices of early stage *wild-type* follicles; images C--C′′ are of methanol-fixed follicles. (A, B) Merged images: anti--actin C4, red; DNase I, green. (A′, B′) Anti--actin C4, white. (A′′, B′′) DNase I, white. (C--E) Merged images: anti--actin C4, green; phalloidin, cyan; WGA, magenta. (C′--E′) Anti--actin C4, white. (C′′--E′′) Phalloidin, white. Scale bars, 50 μm. DNase I uniformly labels a blobby structure within the nurse cell nuclei (A, B, A′′, B′′), and the actin C4 antibody labels the same structure within a subset of the nuclei (A, B, A′, B′). Of note, DNase I does not label the germinal vesicle (A--B′′). On methanol fixation, the actin C4 antibody no longer labels the structured nuclear actin but instead labels F-actin structures within the follicles (C, C′); such fixation prevents phalloidin staining (C′′). RNAi-mediated knockdown of *actin 5C* within the germline results in decreased structured nuclear actin (anti--actin C4) and phalloidin staining of the cortical actin within the nurse cells, whereas both the antibody and phalloidin still label the muscle sheath and phalloidin strongly marks the cortical actin within the follicle cells (E--E′′ vs. D--D′′).](2965fig2){#F2}

To verify that the actin C4 antibody can label F-actin, we used methanol fixation to make the actin within filaments more accessible to the antibody. The actin C4 antibody no longer labeled the structured nuclear actin but instead labeled all canonical F-actin structures ([Figure 2, C and C′](#F2){ref-type="fig"}). As expected, such fixation prevents phalloidin from labeling F-actin ([Figure 2C′](#F2){ref-type="fig"}′).

Because *actin 5C* is the most abundantly expressed actin gene during oogenesis (ModENCODE \[[www.modencode.org/\];](http://www.modencode.org/];) [@B66]), we altered its levels to further test the specificity of the actin C4 antibody. RNA interference (RNAi)--mediated germline knockdown of *actin 5C* results in a reduction in nuclear anti--actin C4 labeling ([Figure 2, E--E′](#F2){ref-type="fig"}′ vs. D--D′′). Knockdown was evident by both immunoblotting (Supplemental Figure S1E) and reduced phalloidin staining within the germline, but normal phalloidin labeling remained in the somatic cells and the muscle sheath ([Figure 2, E′](#F2){ref-type="fig"}′ vs. D′′). Conversely, as discussed in detail later, overexpression of GFP-Actin 5C results in nuclear actin rod formation. These rods label with the actin C4 antibody, and rod formation results in the loss of the structured nuclear actin observed with the actin C4 antibody (see later discussion of [Figure 6, A--B′](#F6){ref-type="fig"}′). Thus both the level of labeling and the structures recognized by the antibody are affected by altering the level of actin within the cells.

Together the foregoing data support that the actin C4 antibody recognizes *Drosophila* actin, both in the cytoplasm and within the nucleus. Throughout the rest of this article, the nuclear actin C4 antibody labeling will be referred to as endogenous nuclear actin. However, it is important to note that this antibody may only recognize a subset, that is, a particular structure and/or modification state, of nuclear actin.

Cofilin and Profilin localize to the nucleus
--------------------------------------------

We interpret the varying levels of endogenous nuclear actin observed within the nurse cells during S5--9 as an indication that nuclear actin is dynamically regulated during this period of development. The localization of actin to the nucleus is regulated by Cofilin (*Drosophila* Twinstar) and Profilin (*Drosophila* Chickadee) in other systems ([@B72]; [@B49]; [@B63]; [@B16]). Immunofluorescence images reveal that both Cofilin and Profilin are found in the nurse cell nuclei during the same stages of follicle development as endogenous nuclear actin ([Figure 3, A--B′′](#F3){ref-type="fig"}). Therefore the factors needed to regulate nuclear actin levels are present during the appropriate developmental time. Subcellular fractionation analysis of Profilin and Cofilin is not currently possible, as Profilin fails to be retained in the nuclei during fractionation ([@B21]), and the Cofilin antibody works poorly for immuno­blotting (unpublished data).

![Cofilin and Profilin are present in the nurse cell nuclei. (A--B′′) Maximum projections of two to four confocal slices of *wild-type* early stage follicles. (A, B) Merged images of nuclear envelope (WGA) in magenta and antibody staining in green. (A--A′′) Anti-Cofilin. (B--B′′) Anti-Profilin. (A′′, B′′) Zoomed-in images of the regions boxed in A′ and B′, respectively. Scale bars, 50 μm (A, B), 10 μm (A′′, B′′). The levels of nuclear Cofilin (A--A′′) and Profilin (B--B′′) appear fairly constant during early oogenesis.](2965fig3){#F3}

Germline expression of GFP-Actin induces stage-specific nuclear actin rod formation
-----------------------------------------------------------------------------------

Our prior work revealed that while germline expression of GFP-Utrophin or Lifeact-GFP using the UAS/GAL4 system ([@B56]) induces nuclear actin rods, these tools also cause severe cytoskeletal defects ([@B61]). Another group demonstrated that N-terminally tagged GFP-Actin could be expressed within the germline using the same UAS/GAL4 system without causing major defects ([@B55]). Thus we assessed whether GFP-Actin could be used to examine nuclear actin. There are six actins in *Drosophila*; two are strongly expressed in the ovary (5C and 42A), one appears to be weakly expressed (57B), and three are not expressed (79B, 87E, and 88F; ModENCODE; [@B66]). In our initial studies on the six actins, we found that strong germline expression (*matGAL4*) of only the GFP-Actins normally expressed during oogenesis (5C, 42A, and 57B) resulted in nuclear actin rod formation in the nurse cell nuclei and the germinal vesicle during S5--9 ([Figure 4, A--F′](#F4){ref-type="fig"}, and unpublished data). It is worth noting that both weak (*nanosGAL4*) and strong (*matGAL4*) germline expression of any of the six GFP-Actins results in severely reduced female fertility or sterility, which does not appear to be due to cytoskeletal defects (Supplemental Figure 2C and unpublished data).

![Germline expression of GFP-Actin induces nuclear actin rods. (A--F′) Maximum projections of two to four confocal slices of early follicles expressing the indicated GFP-Actin in the germline (*matGAL4*). (A--F) Merged images: WGA, magenta; anti-GFP, green. (A′--F′) Anti-GFP, white. Scale bars, 50 μm. Expression of GFP-Actin in the germline results in nuclear actin rod formation (A--F′, yellow arrows). (G) Representative Western blots of subcellular fractionation samples (total lysate, cytoplasmic fraction, nuclear fraction) from the indicated GFP-Actin or GAL4 only (--) blotted for GFP (GFP-Actin), actin (JLA20), Fascin, Lamin Dm0 (nuclear marker), and α-Tubulin (cytoplasmic marker). bl, blank lane; Lad, ladder. (H) Charts quantifying the relative amount of nuclear protein (actin, Fascin, or GFP-Actin) to nuclear Lamin and total protein (actin, Fascin, or GFP-Actin) to total Tubulin from Western blots of three subcellular fractionation experiments. For actin and Fascin values, protein amount was normalized to GAL4 only; GFP protein amount was normalized to GFP-Actin 57B. Error bars, SE. Nuclear and total levels of actin, Fascin, and GFP are not significantly different between GFP-Actin 5C, 42A, or 57B (*p* \> 0.05, ordinary one-way analysis of variance).](2965fig4){#F4}

Both the developmental stage and the GFP-Actin being expressed appeared to affect nuclear actin rod formation. To characterize these differences, we scored the frequency and number of nurse cells exhibiting nuclear actin rods and the length of the rods during S5--6, S7--8, and S9 from confocal stacks labeled for GFP and the nuclear envelope (wheat germ agglutinin \[WGA\]). Follicles were scored as having 0, ≤25, 25--75, or ≥75% of the nurse cells exhibiting actin rods. Rod length was scored as short (≤1/4 diameter of the nucleus), medium (∼1/2 diameter of the nucleus), or long (≥1 diameter of the nucleus). We found that the frequency of nuclear actin rod formation is generally higher in the earlier stages (S5--8) and decreases with development (S9) for GFP-Actin 5C (*p* \< 0.01, Fisher's exact test) and trends similarly with GFP-Actin 42A (*p* = 0.14; Supplemental Figure S2A′ and Supplemental Table S1D). Of note, the early stages are where we also observe higher endogenous nuclear actin levels (Figure 1, A--B′′; see later quantification in [Figure 8E](#F8){ref-type="fig"} and statistical analysis in Supplemental Table S1B; *p* \< 0.0001, Fisher's exact test). GFP-Actin 5C and 42A expression strongly induces nuclear actin rods, and the rods that form tend to be long, whereas GFP-Actin 57B expression results in a low frequency of short nuclear actin rods (Supplemental Figure S2, A--B′; statistical analysis in Supplemental Table S1D). Similar results were observed using a different germline GAL4 driver (*oskGAL4*; unpublished data). These phenotypic differences are not due to fixation conditions, as live imaging revealed similar differences in nuclear actin rod length (Supplemental Figure S3). The differences in actin rod formation also do not appear to be due to the expression level of the transgenes or the level of nuclear GFP-Actin or endogenous nuclear actin ([Figure 4, G and H](#F4){ref-type="fig"}, and unpublished data). This finding suggests the different GFP-Actins have distinct abilities to form nuclear actin rods, similar to the prior finding that the GFP-Actins also differentially incorporate into cytoplasmic actin structures during oogenesis ([@B55]). All subsequent experiments use GFP-Actin 5C.

Nuclear GFP-Actin rod dynamics and composition
----------------------------------------------

We next wanted to assess how rapidly the nuclear GFP-Actin rods form and disassemble. Our initial live-imaging experiments suggested that the rods are stable, as no apparent changes in rod length or number were observed over multiple minutes (Supplemental Movie S3, ∼8 min). To assess whether actin treadmilling occurred on the nuclear GFP-Actin rods, we performed FRAP analysis. A small segment in the middle of a rod was photobleached, and recovery was assessed; if treadmilling were occurring, the bleached area should move along the rod, and fluorescence should recover in the area that was bleached. We found that there was no recovery over 3 min ([Figure 5](#F5){ref-type="fig"} and Supplemental Movie S4). Thus, whereas nuclear actin levels vary during development, with decreased numbers of nurse cells with high levels of nuclear actin ([Figure 1, A--B′](#F1){ref-type="fig"}; quantified later in [Figure 8E](#F8){ref-type="fig"} and statistical analysis in Supplemental Table S1B) and GFP-Actin rod formation (Supplemental Figure S2, A-B′; statistical analysis in Supplemental Table S1D) in the later stages, when rods are present, they are fairly static.

![Nuclear GFP-Actin rods are stable. (A--D) Representative example of FRAP experiments. Single-slice confocal images of GFP-Actin 5C (*UAS GFP-Actin 5C; mat3Gal4*) during FRAP time course showing prebleach, postbleach, middle, and endpoint. Scale bar, 10 μm. (E) Average FRAP recovery curve. Relative fluorescence intensity over time for nine different nuclei from five follicles. Error bars, SD. The nuclear GFP-Actin rods are stable, as the bleached region fails to recover.](2965fig5){#F5}

Because the composition of nuclear actin rods appears to vary across systems, we sought to determine what type of actin rods were forming due to GFP-Actin expression. First, we validated that the GFP rods we observed were indeed actin rods. Using the actin C4 antibody, we found that the nuclear rods colabel for both actin and GFP ([Figure 6, A--B′](#F6){ref-type="fig"}′). We next asked whether the nuclear actin rods label with phalloidin and/or Cofilin. Our images showed that the nuclear actin rods labeled weakly with phalloidin ([Figure 6, C--D′](#F6){ref-type="fig"}′) and exhibited nonuniform Cofilin colocalization ([Figure 6, E--F′](#F6){ref-type="fig"}′). Costaining revealed that the rods labeled with both markers, and, as expected, Cofilin appeared strongest in the areas of weaker phalloidin staining ([Figure 6, G--H′](#F6){ref-type="fig"}′).

![Nuclear GFP-Actin rods contain Cofilin and label with phalloidin. (A--H′′) Maximum projections of two to four confocal slices of follicles from *GFP-Actin 5C; matGAL4* females stained with the indicated antibodies and reagents. (A--F) Merged images: WGA, white; anti-GFP, green; other antibody or stain, red (A, B, anti--actin C4; C, D, phalloidin; E, F, anti-Cofilin). (G--H) Merged images: anti-GFP, green; phalloidin, white; anti-Cofilin, red. (B--B′′, D--D′′, F--F′′, H--H′′) Zoomed-in image of the actin rods pointed out by the white arrows in A--A′′, C--C′′, E--E′′, and G--G′′, respectively. Scale bars, 50 μm (A, C, E, G), and 10 μm (B, D, F, H). Nuclear GFP-Actin rods (yellow arrows) label with antibodies to nuclear actin (A--B′′) and Cofilin (E--F′′) and are weakly labeled by phalloidin (C--D′′). Costaining for both Cofilin and phalloidin reveals that the GFP-Actin rods exhibit regions that label with phalloidin, and in the weak phalloidin regions, the rods contain Cofilin (G--H′′).](2965fig6){#F6}

Fascin regulates nuclear actin rod formation and length
-------------------------------------------------------

We recently found that the actin bundling protein Fascin localizes to the nucleus during *Drosophila* oogenesis ([Figure 1E](#F1){ref-type="fig"}; [@B21]). Because the best-characterized function of Fascin is to bind to and alter the structure of actin, we assessed how changing the level of Fascin expression alters nuclear GFP-Actin rod formation. Images revealed that coexpression of mCherry-Fascin and GFP-Actin 5C in the germline results in increased rod formation compared with follicles from siblings expressing only GFP-Actin ([Figure 7, A and A′](#F7){ref-type="fig"} vs. [B and B′](#F7){ref-type="fig"}). To further characterize the change in nuclear GFP-Actin rod formation, we quantified the frequency and length of the rods as described earlier. We find that expression of Fascin significantly increases rod formation in S5--6 (*p* \< 0.001; Pearson's chi-squared test) and S7--8 (*p* \< 0.0001), and rods are longer in all stages examined (S5--6, *p* \< 0.001; S7--8, *p* \< 0.0001; and S9, *p* \< 0.05; [Figure 7, C and D](#F7){ref-type="fig"}; statistical analysis in Supplemental Table S1A).

![Overexpression of Fascin enhances GFP-Actin rod formation. (A--B′) Maximum projections of two to four confocal slices of S5--9 follicles stained for GFP-Actin (anti-GFP). (A, A′). *UAS mCherry-Fascin/GFP-Actin 5C; oskGAL4/+*. (B, B′) *GFP-Actin 5C/+; oskGAL4/+*. Orange arrows indicate nuclear GFP-Actin rods. Scale bars, 50 μm. (C, D) Charts of the percentage of follicles of the indicated stages and transgenes expressed using *oskGAL4* from 5- to 8-d-old females that exhibit particular frequencies and lengths of nuclear GFP-Actin rods; *n* values for both graphs are indicated across the top of the graph in C. Each follicle within a confocal stack was scored, in a genotypically blinded manner, for the percentage of nurse cells exhibiting nuclear actin rods (C; 0, ≤25, 25--75, or ≥75%) and the length of those rods (D; short, ≤1/4 of the nuclear diameter; medium, ∼1/2 diameter; or long, ≥1 diameter). Overexpression of Fascin enhances both the frequency and length of the nuclear actin rods in S5--6 and S7--8 but only the length during S9 compared with GFP-Actin alone during the same stages (\*\*\**p* \< 0.001 and \**p* \< 0.05, Pearson's chi-squared test). (E--F′′) Maximum projections of two to four confocal slices of two different planes of a S8 *UAS mCherry-Fascin/GFP-Actin 5C; oskGAL4/+* follicle. (E, F) Merged images: WGA, white; anti-GFP, green; anti-dsRed, red. (E′, F′) Anti-GFP, white. (E′′, F′′) Anti-dsRed, white. Scale bars, 50 μm. mCherry-Fascin labels nuclear GFP-Actin rods (orange arrows in E′′ and F′′).](2965fig7){#F7}

Overexpression of Fascin could increase GFP-Actin rod formation by a number of mechanisms. Fascin may alter the total level of nuclear actin, thereby increasing the formation of nuclear actin rods. Subcellular fractionation studies reveal that the level of nuclear GFP-Actin, endogenous actin, and endogenous Fascin are not increased by Fascin overexpression (Supplemental Figure S4). Another means by which overexpression of Fascin could increase nuclear actin rod formation and length is by binding to and stabilizing actin rods within the nucleus. Supporting this idea, we find that mCherry-Fascin labeled GFP-Actin rods ([Figure 7, E--F′](#F7){ref-type="fig"}′, and Supplemental Movie S5).

Fascin regulates endogenous nuclear actin
-----------------------------------------

Although the foregoing studies showed that Fascin regulates GFP-Actin rod formation, it remains to be determined whether Fascin regulates endogenous nuclear actin. Immunofluorescence images reveal that loss of Fascin results in a more uniform, low level of nuclear actin in the nurse cells ([Figure 8, B](#F8){ref-type="fig"} vs. [A](#F8){ref-type="fig"}), whereas overexpression of Fascin results in an increase in the number of nurse cells exhibiting higher levels of endogenous, structured nuclear actin during S5--9 ([Figure 8, D](#F8){ref-type="fig"} vs. [C](#F8){ref-type="fig"}). To further characterize these differences, we scored the percentage of nurse cells exhibiting unstructured nuclear actin (haze) and low, medium, or high levels of structured nuclear actin ([Figure 8E](#F8){ref-type="fig"}; statistical analysis in Supplemental Table S1B). This quantification reveals that structured nuclear actin is present at the highest frequency in S5--6 (∼47% total) and decreases as follicle development progresses (13.5% in S7/8 and 3.3% in S9; *p* \< 0.0001, Fisher's exact test). Loss of Fascin reduces the number of nurse cells exhibiting structured nuclear actin, with 28.6% of S5--6 (*p* \< 0.0001; Pearson's chi-squared test), 4.3% of S7--8 (*p* \< 0.0001), and 1.1% of S9 (nonsignificant \[n.s.\]) nurse cells having structured nuclear actin. GAL4 expression alone, compared with wild type, increases the frequency of nurse cells with structured nuclear actin (statistical analysis in Supplemental Table S1B): 57.4% in S5--6 (*p* \< 0.0001; Pearson's chi-squared test), 27.3% in S7--8 (*p* \< 0.001), and 8% in S9 (n.s.). Expression of mCherry-Fascin further increases the frequency of nurse cells with structured nuclear actin compared with GAL4 expression alone, with 88.9% in S5--6 (*p* \< 0.001, Pearson's chi-squared test), 35% in S7--8 (*p* \< 0.01), and 11.6% in S9 (n.s.).

![Manipulating Fascin alters endogenous nuclear actin. (A--D) Maximum projections of two to four confocal slices of follicles of the indicated genotypes stained for endogenous nuclear actin (anti--actin C4). Scale bars, 50 μm. (E) Chart quantifying the percentage of nurse cells in S5--6, S7--8, and S9 of the indicated genotypes exhibiting unstructured or structured nuclear actin; the number of follicles (*n*) examined is indicated across the top of the chart. Each follicle within a confocal stack was scored, in a genotypically blinded manner, for the percentage of nurse cells exhibiting unstructured nuclear actin haze or low, medium, or high levels of structured nuclear actin. Loss of Fascin (*fascin^sn28/sn28^*) results in a low uniform haze of nuclear actin and a lack of structure compared with *wild-type* follicles (B vs. A, quantified in E; \*\*\**p* \< 0.001, Pearson's chi-squared test), whereas overexpression of Fascin appears to increase the number of nurse cells exhibiting high levels of nuclear actin (orange arrows) compared with GAL4 alone (D vs. C, quantified in E; \*\*\**p* \< 0.001 and \*\**p* \< 0.01, Pearson's chi-squared test). (F) Charts quantifying the relative amount of nuclear protein (endogenous actin or endogenous Fascin) to nuclear Lamin and total protein (endogenous actin or endogenous Fascin) to total Tubulin in the indicated genotypes from Western blots of three subcellular fractionation experiments. Protein amount was normalized to *wild-type*. Error bars, SE. \**p* \< 0.05 and \*\*\**p* \< 0.001, unpaired *t* test with Welch's correction. Neither loss nor overexpression of Fascin significantly alters nuclear actin at the whole ovary level compared with their respective controls (*fascin-/-* to *wild-type*, *p* = 0.4; *Ch-Fascin* to *GAL4*, *p* = 0.7, unpaired *t* test with Welch's correction).](2965fig8){#F8}

The Fascin-dependent changes in endogenous nuclear actin could be due to globally altered nuclear actin levels. To assess this possibility, we used subcellular fractionation (Supplemental Figure S5). We found that reduction or loss of Fascin did not alter nuclear actin levels compared with wild type at the whole ovary level; similarly, overexpression of Fascin did not affect total nuclear actin levels compared with the GAL4 control ([Figure 8F](#F8){ref-type="fig"}, *p* \> 0.05, and Supplemental Figure S5). Endogenous nuclear Fascin levels, as expected, were reduced by the loss of Fascin. Whereas overexpression of Fascin did not affect endogenous nuclear Fascin levels ([Figure 8F](#F8){ref-type="fig"}), total nuclear Fascin levels increased due to mCherry-Fascin localizing to the nucleus (Supplemental Figure S5, red box, and unpublished data). These data indicate that Fascin regulates the accumulation or retention of actin within a subset of nuclei.

Fascin modulates Cofilin to regulate nuclear actin
--------------------------------------------------

One means by which Fascin may regulate endogenous nuclear actin is by altering the localization of the factors regulating the nuclear import and export of actin---Cofilin and Profilin, respectively. Immunofluorescence analyses reveal that, qualitatively, the localization of Profilin is normal when Fascin levels are manipulated (Supplemental [Figure 6, B--C′](#F6){ref-type="fig"} vs. [A--A′](#F6){ref-type="fig"}). To quantify Profilin localization, we generated fluorescence intensity plots from the cytoplasm into the nucleus of nurse cells from S7/8 follicles and used the peak intensity for WGA to define the nuclear boundary. This quantification revealed that the nuclear-to-cytoplasmic ratios of Profilin are unaffected by loss or overexpression of Fascin (Supplemental Figure S6D). Surprisingly, total Profilin levels are reduced by the loss of Fascin (Supplemental Figure S6E). Decreased Profilin levels would be predicted to result in increased nuclear actin due to reduced export of actin from the nucleus. Because loss of Fascin results in decreased endogenous nuclear actin ([Figure 8, B and E](#F8){ref-type="fig"}), it seems unlikely that the reduced Profilin level contributes to the nuclear actin phenotype. The reduction in Profilin may play a role in the late stage cytoplasmic actin defects observed in *fascin* mutant follicles ([@B8]). Alternatively, the reduced Profilin level may simply reflect altered follicle composition of the ovaries in the *fascin* mutant; indeed, the mutant ovaries exhibit a reduction in the number of late stage follicles. Thus we interpret these data to suggest that the main mechanism by which Fascin alters nuclear actin accumulation is not due to Fascin regulating Profilin. However, Fascin does affect Cofilin. Although nuclear Cofilin levels do not appear to be altered by overexpression of Fascin ([Figure 9, D](#F9){ref-type="fig"} vs. [C](#F9){ref-type="fig"}), loss of Fascin qualitatively decreased nuclear Cofilin ([Figure 9, B](#F9){ref-type="fig"} vs. [A](#F9){ref-type="fig"}). Quantification of nuclear-to-cytoplasmic ratios of Cofilin by fluorescence intensity plots reveals that the *wild-type* ratio is 1.38 ± 0.035 (SE), and this ratio is reduced to 0.962 ± 0.013 in *fascin* mutants ([Figure 9E](#F9){ref-type="fig"}, *p* \< 0.0001). Total *cofilin* transcript levels, as assessed by quantitative reverse transcriptase PCR, are unaffected by the loss of Fascin but increase when Fascin is overexpressed ([Figure 9F](#F9){ref-type="fig"}). Together these data suggest that Fascin regulates Cofilin by an unknown mechanism to modulate nuclear actin levels.

![Loss of Fascin reduces nuclear Cofilin levels. (A--D) Maximum projections of two to four confocal slices of follicles of the indicated genotypes stained for Cofilin; note that these are the same follicles shown in [Figure 8](#F8){ref-type="fig"}. Scale bars, 50 μm. (E) Chart depicting the average nuclear-to-cytoplasmic relative fluorescence intensity of Cofilin in nurse cells from S7--8 follicles; the number of nurse cells (*n*) examined is indicated across the top of the chart. Briefly, the fluorescence intensity along a line traversing from the cytoplasm into the nucleus from two to three nurse cells from a minimum of seven different follicles from each genotype, in a genotypically blinded manner, was analyzed as described in *Materials and Methods*. Loss of Fascin significantly reduced the nuclear level of Cofilin, whereas overexpression of Fascin did not alter the distribution of Cofilin. Error bars, SE. \*\*\**p* \< 0.001, unpaired *t* test with Welch's correction. (F) Chart depicting the normalized mRNA expression of *cofilin* from whole ovary preparations. Error bars, SE. Reduction of Fascin expression does not alter *cofilin* expression relative to *wild-type*. Overexpression of Fascin results in a significant increase in *cofilin* expression relative to its GAL4 control (*Ch-Fascin* to *GAL4*, *p* \< 0.05, unpaired *t* test with Welch's correction).](2965fig9){#F9}

Supporting this idea, we find that Fascin and Cofilin dominantly interact. Heterozygosity for a null mutation in *fascin* has little effect on the frequency of nurse cells exhibiting structured nuclear actin ([Figure 10, A](#F10){ref-type="fig"} and quantified in [D](#F10){ref-type="fig"}; statistical analysis in Supplemental Table S1C), and heterozygosity for *cofilin* (*Drosophila twinstar*) slightly reduces the number of nurse cells with structured nuclear actin during S5--6 (*p* \< 0.001, Fisher's exact test) and S9 (*p* \< 0.05; [Figure 10, B and quantified in D](#F10){ref-type="fig"}). However, follicles from flies that are heterozygous for mutations in both *fascin* and *cofilin* exhibit a significant loss of structured nuclear actin compared with either heterozygote alone in S5--9 ([Figure 10, C](#F10){ref-type="fig"} and quantified in [D](#F10){ref-type="fig"}; *p* \< 0.001, Fisher's exact test; statistical analysis in Supplemental Table S1C). This loss of nurse cells with structured nuclear actin is not due to a global decrease in nuclear actin levels, as subcellular fractionation analysis of whole ovaries indicates that total nuclear actin levels are similar between *wild-type*, *fascin−/+*, *cofilin−/+*, and *fascin−/+;cofilin−/+* (Supplemental Figure S7). These data support a model in which Fascin regulates Cofilin to control nuclear actin, determining when and which nuclei accumulate higher levels of structured nuclear actin.

![Fascin genetically interacts with Cofilin to regulate nuclear actin. (A--C) Maximum projections of two to four confocal slices of follicles stained for nuclear actin (anti--actin C4). (A) *fascin^sn28^/ +*, (B) *cofilin^tsr1^*/*+*, and (C) *fascin^sn28^/ +; cofilin^tsr1^/+*. Orange arrows indicate structured nuclear actin within the nurse cells. Scale bars, 50 μm. (D) Chart quantifying the percentage of nurse cells in S5--6, S7--8, and S9 of the indicated genotypes exhibiting unstructured or structured nuclear actin; the number of follicles (*n*) examined is indicated across the top of the chart. Each follicle within a confocal stack was scored, in a genotypically blinded manner, for the percentage of nurse cells exhibiting unstructured nuclear actin haze or low, medium or high levels of structured nuclear actin. Heterozygosity for a null allele of *fascin* has minimal effect on the frequency of nurse cells with structured nuclear actin levels, whereas heterozygosity for *cofilin* (*Drosophila twinstar, tsr*) exhibits reduced structured nuclear actin in S5/6 and S9 compared with *fascin−/+* (A and B, quantified in D). Double heterozygotes for mutations in *fascin* and *cofilin* result in a striking reduction in the number of nurse cells with structured nuclear actin compared with either heterozygote alone (C vs. A and B; quantified in D); red asterisks indicate significant difference from both individual heterozygotes at the same stages. \*\*\**p* \< 0.001 and \**p* \< 0.05; Fisher's exact test.](2965fig10){#F10}

DISCUSSION
==========

Nuclear actin is found at varying levels within the nurse cells, is present in a subset of early follicle cells, and is highly enriched in the germinal vesicle during S5--9 of *Drosophila* oogenesis. We used the broad-specificity actin C4 antibody ([@B36]) to examine endogenous nuclear actin. Analysis of this antibody supports that it recognizes actin, because altering actin expression affects its labeling pattern, when it labels nuclear structures it colocalizes with nuclear DNase I, which marks monomeric actin, and finally, methanol fixation relocalizes its labeling to F-actin structures. However, not all nuclear actin is recognized by the antibody. Indeed, DNase I uniformly labels a blobby structure within the nurse cell nuclei, whereas the actin C4 antibody labels only a subset of these nuclei. Furthermore, in many studies on nuclear actin, different antibodies to actin routinely label distinct nuclear structures ([@B58]; [@B32]; [@B3]). Thus the actin C4 antibody likely labels a subset of nuclear actin. It remains to be determined what the structure of this actin is and whether other pools of nuclear actin exist in these cells.

During the same stages in which we observe endogenous nuclear actin, ectopic germline expression of GFP-Actin exhibits nuclear actin rod formation. Similarly, expression of the actin-labeling reagents GFP-Utrophin and Lifeact-GFP results in nuclear actin structures during these stages ([@B61]). These structures likely form due to increased nuclear actin levels resulting from the higher expression of actin in the case of GFP-Actin and stabilization of nuclear actin in the cases of GFP-Utrophin and Lifeact-GFP. These findings suggest that nuclear actin levels and structures are tightly regulated during development.

Although the physiological relevance of nuclear actin rods remains debated, cell culture--based screens assessing nuclear actin rods have identified novel regulators of nuclear actin ([@B54]). Here we used nuclear GFP-Actin rod formation to uncover the role of the actin bundling protein Fascin in modulating nuclear actin in an in vivo, developmental context. Overexpression of Fascin enhances both the length and frequency of formation of nuclear GFP-Actin rods. This finding is not specific to nuclear GFP-Actin, as overexpression of Fascin increases the frequency of nurse cells with high levels of endogenous, structured nuclear actin, whereas loss of Fascin results in a uniform, low level of nuclear actin. Because the total level of nuclear actin within the ovary is not affected by genetically manipulating Fascin, these findings suggest that Fascin regulates cell-specific accumulation of nuclear actin. Thus, by screening for modifiers of nuclear GFP-Actin rod formation during *Drosophila* oogenesis, regulators of endogenous nuclear actin can be identified.

Multiple lines of evidence indicate that Fascin regulates Cofilin to control nuclear actin. Loss of Fascin results in decreased nuclear Cofilin, whereas total Cofilin levels appear unchanged. In addition, Fascin and Cofilin genetically interact. Follicles from flies that are heterozygous for mutations in both *fascin* and *cofilin* exhibit a striking reduction in the number of nurse cells with high levels of structured nuclear actin compared with either heterozygote alone. These data lead to a model in which Fascin promotes the nuclear localization of Cofilin, and therefore actin, in a cell-specific manner within the *Drosophila* germline. Given that we recently showed that Fascin localizes to the nucleus and nuclear periphery in addition to the cytoplasm ([@B21]; [@B74]), Fascin could act at any of these cellular locations to modulate Cofilin and nuclear actin.

Cofilin has both cytoplasmic and nuclear roles in regulating nuclear actin. In the cytoplasm, Cofilin binds to and severs F-actin ([@B34]); this activity alters the cellular levels of F- versus G-actin. Because increased G-actin levels lead to nuclear actin accumulation ([@B49]), cytoplasmic Cofilin regulates the pool of actin available for transport to the nucleus. Of interest, Cofilin severing activity is enhanced on Fascin-bundled actin filaments ([@B7]). Thus loss of Fascin's bundling activity is predicted to decrease Cofilin activity and G-actin levels, reducing nuclear actin accumulation. Cofilin also directly binds monomeric actin and facilitates its import into the nucleus ([@B49]; [@B16]). In the nucleus, Cofilin can stabilize nuclear actin structures by forming Cofilin--actin rods ([@B45]). Because Fascin localizes to the nucleus, nuclear Fascin may prevent nuclear export of Cofilin, thereby stabilizing nuclear actin structures.

Phosphorylation inhibits both Cofilin's actin severing ([@B2]) and nuclear import functions ([@B16]). Two kinases phosphorylate Cofilin: LIM kinase (LIMK) and Tes kinase (*Drosophila* Cdi). Both kinases are expressed during *Drosophila* oogenesis (ModENCODE). Of note, Fascin binds to LIMK in other systems and relocates it to sites of actin bundle formation ([@B31]). Thus cytoplasmic Fascin may regulate LIMK to control the phosphorylation of Cofilin and thereby regulate nuclear actin. Fascin may also regulate the expression or activity of Ssh (*Drosophila* Slingshot), the phosphatase for Cofilin. Of interest, a recent genetic screen for modifiers of nuclear actin rod formation uncovered a number of proteins that regulate Cofilin ([@B15]). It will be interesting to examine whether Fascin affects any of these newly identified Cofilin regulators to modulate nuclear actin.

Fascin also regulates the structure of nuclear actin. Overexpression of Fascin results in curved and often circular nuclear actin rods. Loss of Fascin also alters nuclear actin structure, as there is a reduction in the number of nuclei exhibiting structured, endogenous nuclear actin. Because mCherry-Fascin localizes to nuclear GFP-Actin rods, Fascin modulation of nuclear actin structure could be direct. It is possible that Fascin also indirectly regulates nuclear actin structure. Although we favor the model in which nuclear Fascin controls nuclear actin structure, Fascin at any cellular location may modulate the complement of actin binding proteins within the nucleus to regulate nuclear actin architecture.

Our finding that nuclear actin is tightly controlled during *Drosophila* oogenesis strongly suggests that nuclear actin plays important but unknown functions. Supporting this idea, germline expression of any of the six GFP-Actins results in female sterility without any striking defects in cytoplasmic F-actin structures or follicle morphogenesis. One potential role of nuclear actin may be to modulate DNA replication within the nurse cells. During S5--9, the nurse cells undergo asynchronous endocycles ([@B37]). Nuclear actin may serve a similar role in the follicle cells, as patches of these cells within a given follicle also exhibit varying levels of nuclear actin. Alternatively, nuclear actin may regulate transcription. The nurse cells actively transcribe components that will ultimately be provided to the oocyte to mediate embryonic development. Of interest, strong germline expression of GAL4 increases the frequency of nurse cells with structured nuclear actin; this increase in nuclear actin may be due to increased transcription within the cells or strong expression of GAL4 causing cellular stress. Another potential role of nuclear actin is structural, maintaining nuclear shape in response to mechanical forces. The nurse cell nuclei undergo dramatic shape changes during S5--9. During S5, the nuclei are round, but as development progresses, the nuclei become increasingly invaginated ([@B10]). Of note, endogenous nuclear actin and GFP-Actin rod formation are inversely correlated with nuclear envelope invagination in the nurse cells. The high level of nuclear actin within the germinal vesicle may also play a structural role, as it is in a very large cytoplasm and likely has to resist substantial pressure. Thus a nuclear actin meshwork similar to that in *Xenopus* oocytes ([@B6]) may maintain germinal vesicle shape and integrity in *Drosophila*. Nuclear actin may also serve as a storage facility for monomeric actin. During S5--9, the nurse cells rapidly grow in size and need a large pool of G-actin for cortical actin growth. However, given that the endogenous, structured nuclear actin substantially decreases in S9 compared with S5--8 and is rarely detected in S10A, when the nurse cells are still increasing in size, it is unlikely that this is a major role of structured nuclear actin during follicle development. Further studies are needed to uncover which of these potential actions or other novel functions nuclear actin plays during *Drosophila* oogenesis.

Our finding that Fascin regulates Cofilin to modulate nuclear actin is likely relevant beyond *Drosophila* oogenesis. Indeed, Fascin's diverse cellular locations and activities are conserved from invertebrates to humans ([@B30]; [@B74]; [@B21]). Furthermore, the majority of the new nuclear actin regulators discovered in screens using cultured *Drosophila* cells also modulate nuclear actin in mammalian cells ([@B54]; [@B15]). Thus our study provides the foundation to explore the in vivo, physiologically important regulation and function of nuclear actin.

MATERIALS AND METHODS
=====================

Fly stocks
----------

Fly stocks were maintained on cornmeal/agar/yeast food at 21°C, except where noted. Before immunofluorescence or Western blot analysis, flies were fed wet yeast paste daily for 3--7 d. Unless otherwise noted, *yw* was used as the *wild-type* control. The following stocks were obtained from the Bloomington *Drosophila* Stock Center (Bloomington, IN): UASp RNAi *actin 5C* (TRiP.HMS02487), UASp GFP-Actin 5C, UASp GFP-Actin 42A, UASp-GFP-Actin 57B, UASp GFP-Actin 79B, UASp GFP-Actin 87E, UASp GFP-Actin 88F, *sn^x2^*, *tsr^1^*, *tsr^N121^*, *tsr^k05633^*, and *matα*Gal4 (third chromosome). The *sn^28^*, UASp mCherry-Fascin, and *nanosGAL4* lines were a generous gift from Jennifer Zanet (Centre de Biologie du Développement, Université de Toulouse, Toulouse, France; [@B73]), and the *oskarGal4* lines (second and third chromosomes) were a generous gift from Anne Ephrussi (European Molecular Biology Laboratory, Heidelberg, Germany; [@B64]). Expression of UASp RNAi *actin 5C* was achieved by crossing to *matαGal4*, maintaining fly crosses at 21 or 25°C, and maintaining progeny at 29°C. Expression of UASp GFP-Actin and/or UASp Cherry-Fascin was achieved by crossing to *matαGal4* or *oskarGal4* flies, maintaining fly crosses at 21°C, and maintaining progeny at 25°C.

Fertility assays
----------------

Three females (∼4 d old, fed wet yeast every day before mating) of the indicated genotypes were allowed to mate with two or three *wild-type* (*yw*) males for 2 d. Matings were performed in triplicate for each genotype. Fresh wet yeast was provided daily. The flies were then transferred to a fresh vial, provided wet yeast, and allowed to lay eggs for 24 h. The adults were removed after 24 h, and the resulting adult progeny were counted ∼18 d later. The number of progeny per female was determined for each vial, and the average and SD of the three independent vials per genotype was calculated. Fertility assays were performed at 25°C. Statistical analysis was performed using Prism (GraphPad Software, La Jolla, CA).

Immunofluorescence
------------------

Whole-mount *Drosophila* ovary samples were dissected into Grace's insect medium (Lonza, Walkersville, MD) and fixed for 10 min at room temperature in 4% paraformaldehyde in Grace's insect medium, except for the instance of methanol fixation, which was done for 10 min at 4°C in −20°C methanol. Briefly, samples were blocked by washing in Triton antibody wash (1× phosphate-buffered saline \[PBS\], 0.1% Triton X-100, and 0.1% bovine serum albumin) six times for 10 min each at room temperature. Primary antibodies were incubated overnight at 4°C, except for actin C4, 2G2, and 1C7, and Cofilin which were incubated for a minimum of 20 h at 4°C. The following additional antibodies and concentrations were used: rabbit anti-GFP 1:2000 (preabsorbed on *yw* ovaries at 1:20 and used at 1:100; Torrey Pines Biolabs, Secaucus, NJ); goat anti-GFP 1:2000 (preabsorbed on *yw* ovaries at 1:20 and used at 1:100; Fitzgerald, Acton, MA); rabbit anti-DsRed 1:500 (Clontech, Mountain View, CA); mouse anti--actin C4 1:50 (EMB Millipore, Billerica, MA); mouse anti--actin 2G2 1:25 (EMB Millipore); mouse anti-1C7 1:25 (BS Antibody Facility, Braunschweig, Germany); rabbit anti-cofilin AB3 1:100 (SAB Signalway, College Park, MD); and mouse anti-Profilin undiluted (obtained from the Developmental Studies Hybridoma Bank \[DSHB\] developed under the auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biology, University of Iowa, Iowa City, IA; chi 1J, Cooley, L. \[ [@B69]\]). After six washes in Triton antibody wash (10 min each), secondary antibodies were incubated overnight at 4°C or for ∼4 h at room temperature. The following secondary antibodies were used at 1:250--1:500: AF488::goat anti-mouse, AF568::goat anti-mouse (immunoglobulin M--specific secondary was used for actin 2G2 staining), AF633::goat anti-mouse, AF488::goat anti-rabbit, AF568::goat anti-rabbit, AF488::donkey anti-goat, and AF568::donkey anti-rabbit (Life Technologies, Grand Island, NY). Alexa Fluor 647--, rhodamine- or Alexa Fluor 488--conjugated phalloidin (Life Technologies) was included with secondary antibodies at a concentration of 1:100--1:250. Alexa Fluor 555-- or Alexa Fluor 647--conjugated WGA (Life Technologies) was included with the secondary antibody at a concentration of 1:500. After six washes in Triton antibody wash (10 min each), 4′,6-diamidino-2-phenylindole (5 mg/ml) staining was performed at a concentration of 1:5000 in 1× PBS for 10 min at room temperature. Ovaries were mounted in 1 mg/ml phenylenediamine in 50% glycerol, pH 9 ([@B51]). All experiments were performed a minimum of three independent times.

Image acquisition and processing
--------------------------------

Microscope images of fixed *Drosophila* follicles were obtained using LAS AF SPE Core software on a Leica TCS SPE mounted on a Leica DM2500 using an ACS APO 20×/0.60 IMM CORR -/D or an ACS APO 63×/1.30 Oil CS 0.17/E objective (Leica Microsystems, Buffalo Grove, IL) Maximum projections (two to five confocal slices), merged images, rotation, and cropping were performed using ImageJ software ([@B1]). To aid in visualization, all panels were brightened by 30% in Photoshop (Adobe, San Jose, CA).

Live imaging
------------

Whole ovaries were dissected from flies fed wet yeast paste for 4--6 d and maintained at 25°C. Ovaries were dissected in Stage 9 medium ([@B53]): Schneider's medium (Life Technologies), 0.6× penicillin/streptomycin (Life Technologies), 0.2 mg/ml insulin (Sigma-Aldrich, St. Louis, MO), and 15% fetal bovine serum (Atlanta Biologicals, Flowery Branch, GA). Ovarioles and individual early stage follicles (S3--9) were hand dissected and either placed in a drop of medium or embedded in 1.25% low-melt agarose (IBI Scientific, Peosta, IA) made with Stage 9 media on a coverslip-bottom dish (MatTek, Ashland, MA; [@B22]). Live imaging of GFP-Actin was performed using Zen software on a Zeiss 700 LSM mounted on an Axio Observer.Z1 using a LD C-APO 40×/1.1 W/0 objective (Carl Zeiss Microscopy, Thornwood, NY). For FRAP experiments, GFP-Actin was photobleached using 100% laser power of the 488-nm laser for 50 iterations. From 100 to 200 images were obtained in a time series (three prebleach and the rest postbleach) with no delay between images. FRAP recovery curve analysis was performed using the FRAP Calculator Package plug-in in ImageJ ([@B1]). FRAP recovery curves of multiple nuclei were averaged and analyzed using Excel (Microsoft, Redmond, WA).

Quantification of nuclear actin rod frequency and length
--------------------------------------------------------

Quantification of nuclear actin rods was performed on confocal image stacks of follicles stained with anti-GFP and WGA. Genotypically deidentified images were analyzed using ImageJ; as necessary, brightness and contrast were adjusted to score all of the actin rods present. Data were collected for S5--6, S7--8, and S9. Follicle staging was assigned based on morphology and size. For each follicle, the percentage of nurse cells exhibiting nuclear actin rods was assessed and binned into four categories: none, ≤25, 25--75, or ≥75%. The rods were then scored for length: short (≤1/4 diameter of nucleus), medium (∼1/2 diameter of nucleus), or long (≥1 diameter). Data were analyzed using Excel. Statistical analysis was performed using R ([www.r-project.org](http://www.r-project.org)).

Quantification of endogenous nuclear actin from immunofluorescence
------------------------------------------------------------------

Quantification of endogenous nuclear actin was performed on confocal image stacks of follicles stained with anti-actin C4 and WGA. Genotypically deidentified images were analyzed using ImageJ; as necessary, brightness and contrast were adjusted to score all of the structured nuclear actin present. Data were collected for S5--6, S7--8, and S9. For each follicle, the number of nurse cells exhibiting unstructured (haze) or structured nuclear actin, binned into three categories, low, medium, and high levels, was scored. Data were analyzed using Excel. Statistical analysis was performed using R.

Quantification of nuclear/cytoplasmic levels from immunofluorescence
--------------------------------------------------------------------

Quantification of the nuclear-to-cytoplasmic ratios of Profilin and Cofilin was performed on confocal image stacks of follicles stained with anti-Profilin or anti-Cofilin, respectively, and WGA. Fluorescence intensity plots of nurse cell cytoplasm and nuclei were generated from a single slice of deidentified 20× confocal images using ImageJ software ([@B1]). Briefly, a line segment was drawn from the cytoplasm into the nucleus, and the plot profile function was used to generate a fluorescence intensity plot for each desired channel. The raw data files generated by these plot profiles were analyzed in Excel, with each plot line normalized to the peak value within that plot, creating intensity plots where the maximum observed fluorescence of a given line is represented by a value of 1.0 relative fluorescence intensity (RFI). The nuclear boundary was marked by the highest WGA value. All RFI averaging was performed in Excel. The cytoplasm was defined as all of the plot points to the left of the nuclear boundary. The nucleus was defined as the plot points at and to the right of the peak WGA value. Statistical analysis was performed using R.

Quantitative reverse transcriptase PCR
--------------------------------------

Whole ovaries were dissected from adult flies provided wet yeast paste for 3--5 d in room temperature Grace's insect medium and homogenized in TRIzol (Thermo Scientific, Waltham, MA). Total RNA was extracted following manufacturer's protocol, and samples were treated overnight with RNase-free DNase (Roche, Indianapolis, IN). After quantification, 400 ng of RNA was subjected to first-strand cDNA synthesis using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA). Quantitative real-time PCR analysis was preformed using iQ SYBR Green Supermix (Bio-Rad) following the manufacturer's protocol on the Bio-Rad CFX96 Real-Time system. Primers for qPCR experiments were designed to span exon--exon junctions against *twinstar* (forward, 5′-GTGAAAGAAGGCGGAAGGTTAA-3′; reverse, 5′-CACAGTTACACCAGAAGCCATT-3′) and reference genes *succinate dehydrogenase, subunit A* (forward, 5′-CAAGGTTGTCGATAGGTCG-3′; reverse, 5′-CTCACAATAGTCATCTGGGC-3′) and *cyclophillin-33* (forward, 5′-TGATACCCGAGTTTATGTGTC-3′; reverse, 5′-GGCCATTGAAAGAGTTCCA-3′).

Each primer was ∼100% efficient when examined against a serial dilution of cDNA and produced a single product observed through endpoint melt-curve analysis. The fold change in *twinstar* expression was determined using the 2-ΔΔ*^Ct^* method of quantification against two reference genes. Each sample was assessed in triplicate from three independent experiments. Data were analyzed and statistical significance determined against respective control using Excel.

Subcellular fractionation
-------------------------

Subcellular fractionation was performed using methods modified from [@B24]). In short, whole ovaries from adult females that had been provided wet yeast paste for 3--5 d were dissected in room temperature Grace's insect medium. Ovaries were lysed in 1.5-ml microcentrifuge tubes on ice in 100 μl of hypotonic buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.9, 1.5 mM MgCl~2~, 10 mM KCl, 0.5 mM dithiothreitol, 20 μg/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride) with gentle grinding with a plastic pestle. A rough nuclear pellet was separated from the cytoplasmic fraction by centrifugation at 300 × *g* for 10 min at 4°C (Centrifuge 5415R; Eppendorf, Hauppauge, NY). The nuclear pellet was further clarified using a 25% iodixanol gradient (OptiPrep 60% iodixanol solution \[Sigma-Aldrich\] diluted with 0.25 M sucrose, 25 mM KCl, 5 mM MgCl~2~, 20 mM Tris-Cl, pH 7.8). Specifically, the nuclear pellet was resuspended in iodixanol and centrifuged at 10,000 × *g* for 10 min at 4°C. Iodixanol supernatant was removed and the step repeated one time before resuspending the nuclear pellet in 50 mM Tris-HCl, pH 7.6, 500 mM NaCl, 1% Triton X-100, 0.1% SDS, and 10 mM MgCl~2~. Equivalent volumes of protein lysates for total cell lysate, cytoplasmic fraction, and nuclear fraction were analyzed by standard SDS--PAGE/Western blot analysis (see later description) using the following primary antibodies: mouse anti-Fascin 1:50--1:100 (sn7c, Cooley, L., DSHB), rabbit anti-GFP (Torre Pines) 1:10000; mouse anti-Lamin Dm0 (ADL195, Fisher, P.A., DSHB) 1:200; mouse anti-actin (JLA20, Lim, J.J-C, DSHB) 1:100--1:500; mouse anti--actin C4 (Signalway) 1:5000; and mouse anti-tubulin (Sigma-Aldrich) 1:5000. Nuclear Fascin, actin, and GFP-Actin densitometry was normalized to nuclear Lamin, and total levels were normalized to total α-Tubulin. Densitometry values were made relative to respective experimental controls. Data were analyzed using Excel and Prism. A minimum of three independent experiments were performed for each subcellular fractionation experiment.

Western blotting
----------------

Western blots were performed using standard methods with the primary antibodies referred to in the *Subcellular fractionation* section and the following antibodies: mouse anti-Profilin (chi 1J, Cooley, L., DSHB) 1:10; mouse anti--actin 2G2 (Millipore) 1:1000, and mouse anti--actin 1C7 (BS Antibody Facility) 1:500. All blots had 0.1% Tween 20 added to the primary antibody in 5% milk diluted in 1× Tris-buffered saline. The following secondary antibodies were used: Peroxidase-AffiniPure Goat Anti-Rabbit IgG (H + L) (1:5000) or Peroxidase-AffiniPure Goat Anti-Mouse IgG (H + L) (1:5000; Jackson ImmunoResearch Laboratories, West Grove, PA). Blots were developed with SuperSignal West Pico or Femto Chemiluminescent Substrate (Thermo Scientific, Waltham, MA) and imaged using ChemiDoc-It Imaging System and VisionWorksLS software (UVP, Upland, CA). Bands were quantified using the gel analyzer function of ImageJ ([@B1]). Densitometry values were made relative to respective experimental controls. Data were analyzed using Excel and Prism. A minimum of three independent experiments were performed for each Western blotting experiment.
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F-actin

:   filamentous actin

FRAP

:   fluorescence recovery after photobleaching

S*x*

:   Stage *x* of oogenesis

WGA

:   wheat germ agglutinin.
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